🔖
Cite This Article
AKSOY, Y., EYİ, Y. E. (2014). The Timing of Antiviral Drugs in the Treatment of Herpes Zoster Ophthalmicus. Journal of Emergency Medicine Case Reports, Cilt: 5 - Sayı: 11. https://ajindex.com/articles/419713
Journals / Journal of Emergency Medicine Case Reports / 2014 / Cilt: 5 - Sayı: 11
The Timing of Antiviral Drugs in the Treatment of Herpes Zoster Ophthalmicus
- Pages
- —
- Publication Date
- 2014-11-01
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (2)
- Sayhan M B, Sezenler E, Nalbur I H, Yağcı G, Gezer E. Herpes Zoster Oftalmikus JAEMCR 2012; 3: 74-6. [CrossRef] Catron T, Hern HG. Herpes Zoster Ophthalmicus. West J Emerg Med 2008; 9: 174-6.
- Heymann AD, Chodick G, Karpati T, Kamer L, Kremer E, Green M.S, et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection 2008; 36: 226-30. [CrossRef] Gross G, Schöfer H, Wassilew S, Friese K, Timm A, Guthoff R, et al. Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol 2003; 26: 277-89; discussion 291-3. [CrossRef] Schmader K, Gnann J.W. Watson C.P. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis 2008;197: 207-15. [CrossRef] Galluzzi KE. Managing herpes zoster and postherpetic neuralgia. J Am Osteopath Assoc 2009; 109: 7-12.